73 results
Page 3 of 4
6-K
vwvbbot596az ui
14 May 20
Current report (foreign)
7:25am
424B5
7h3com 0pzrh
12 May 20
Prospectus supplement for primary offering
12:02pm
424B5
5ksa3arggpwc yokfos8
11 May 20
Prospectus supplement for primary offering
9:23am
6-K
am5 5b8kq
14 Nov 19
Current report (foreign)
7:01am
6-K/A
e1hr96o4
29 Aug 19
Current report (foreign) (amended)
5:25pm
6-K
oc67uvqi1e 9wg
13 Aug 19
Current report (foreign)
7:00am
6-K
EX-10.1
oks0l1h
17 May 19
Current report (foreign)
5:20pm
424B5
ucag9bam8xkwc46jyv
17 May 19
Prospectus supplement for primary offering
5:19pm
6-K
ymp1isv
15 May 19
Current report (foreign)
7:00am
6-K
EX-99.1
phuruj2
16 Nov 18
Current report (foreign)
8:46am
6-K
pbtbdzyy4af65k93p
16 Aug 18
Current report (foreign)
7:00am
424B5
ppq8gk6p
27 Jun 18
Prospectus supplement for primary offering
9:30am
6-K
EX-99.1
g89elgu3qrr psqv3v
23 Oct 17
VBL Therapeutics Celebrates Opening of its New Gene Therapy Manufacturing Plant and Company Headquarters
12:00am
6-K
EX-99.1
m1voemtx2wetij g2n
20 Oct 17
VBL Therapeutics Announces Orphan Drug Designation for VB-111 In Europe
12:00am
20-F/A
EX-4.3
izqromh4j2ooz8o4r5
11 Oct 17
Annual report (foreign) (amended)
12:00am